Ann Dahlberg
Overview
Explore the profile of Ann Dahlberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehta R, Lee S, Gooley T, Thur L, Dahlberg A, Delaney C, et al.
Blood Adv
. 2025 Feb;
PMID: 39969207
No abstract available.
2.
Cox E, Summers C, Milano F, Dahlberg A, Bleakley M, Sandmaier B, et al.
Ann Hematol
. 2024 Jul;
103(9):3737-3743.
PMID: 39003390
With advancements in novel therapeutics, it is unclear whether third hematopoietic cell transplantation (HCT3) has a place in the treatment of recurrent hematopoietic malignancies. We evaluated patients with hematologic malignancies...
3.
Krakow E, Brault M, Summers C, Cunningham T, Biernacki M, Black R, et al.
Blood
. 2024 Apr;
144(10):1069-1082.
PMID: 38683966
Relapse is the leading cause of death after allogeneic hematopoietic stem cell transplantation (HCT) for leukemia. T cells engineered by gene transfer to express T cell receptors (TCR; TCR-T) specific...
4.
Keller M, Hanley P, Chi Y, Aguayo-Hiraldo P, Dvorak C, Verneris M, et al.
Nat Commun
. 2024 Apr;
15(1):3258.
PMID: 38637498
Viral infections remain a major risk in immunocompromised pediatric patients, and virus-specific T cell (VST) therapy has been successful for treatment of refractory viral infections in prior studies. We performed...
5.
Ostlund A, Flaring U, Larsson P, Kaiser S, Vermin L, Frisk T, et al.
Eur J Pediatr
. 2022 Jun;
181(8):3031-3038.
PMID: 35652985
Conclusion: Our results indicate that VTEs not related to a vascular catheter are a rare event even in a selected group of severely ill small children considered to be at...
6.
Bleakley M, Sehgal A, Seropian S, Biernacki M, Krakow E, Dahlberg A, et al.
J Clin Oncol
. 2022 Jan;
40(11):1174-1185.
PMID: 35007144
Purpose: Graft-versus-host disease (GVHD) causes morbidity and mortality following allogeneic hematopoietic cell transplantation. Naive T cells (T) cause severe GVHD in murine models. We evaluated chronic GVHD (cGVHD) and other...
7.
Summers C, Wu Q, Annesley C, Bleakley M, Dahlberg A, Narayanaswamy P, et al.
Transplant Cell Ther
. 2021 Oct;
28(1):21-29.
PMID: 34644605
Consolidative hematopoietic cell transplantation (HCT) after CD19 chimeric antigen receptor (CAR) T cell therapy is frequently performed for patients with refractory/ relapsed B cell acute lymphoblastic leukemia (B-ALL). However, there...
8.
Dahlberg A, Kurtzberg J, Boelens J, Martinez C, Carpenter P, Tewari P
Transplant Cell Ther
. 2021 Sep;
27(12):968-972.
PMID: 34571212
Cord blood (CB) is the stem cell source of choice for approximately 30% of pediatric patients undergoing hematopoietic cell transplantation. Cord blood is readily available and is a particularly appealing...
9.
Sharma A, Huang S, Li Y, Brooke R, Ahmed I, Allewelt H, et al.
Bone Marrow Transplant
. 2021 Sep;
56(12):2997-3007.
PMID: 34480120
Long-term outcomes after allogeneic hematopoietic cell transplantation (HCT) for therapy-related myeloid neoplasms (tMNs) are dismal. There are few multicenter studies defining prognostic factors in pediatric patients with tMNs. We have...
10.
Hill J, Zamora D, Xie H, Thur L, Delaney C, Dahlberg A, et al.
Blood Adv
. 2021 Aug;
5(16):3113-3119.
PMID: 34402885
Cytomegalovirus (CMV)-seropositive umbilical cord blood transplantation (CBT) recipients have a high incidence of CMV-associated complications. There are limited data regarding the efficacy of letermovir for preventing clinically significant CMV infection...